1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Kanabo Group Plc

Kanabo Group Plc

KNB.L
Kanabo Group PlcGB flagLondon Stock Exchange
0.23
GBp
-0.07
- -
1.42MMarket Cap
Kanabo Group Plc
KNB.L
(London Stock Exchange)

Recent

price

0.23

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
FRC
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.01
-0.01
-0.01
-0.02
-0.01
-0.02
-0.01
Basic EPS, GAAP
-0.01
-0.01
-0.01
-0.02
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.01
- -
-0.1
0.01
-0.01
-0.01
Book Value per Share
0.07
0.04
0.02
- -
0.02
0.01
0.01
Tangible Book Value per Share
15
29
29
29
324
415
537
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
1
Sales/Revenue/Turnover
- -
- -
- -
-938.33
-3,841.1
-1,006.14
-335.64
Operating Margin (%)
- -
- -
- -
- -
- -
1
1
Depreciation Expense
- -
- -
- -
-1
-5
-7
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
-985
-6,234.25
-1,138.81
-892.4
Profit Margin (%)
1
1
1
- -
4
3
3
Working Capital
- -
- -
- -
- -
- -
1
- -
LT Debt
1
1
1
- -
5
12
8
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-37.59
-177.51
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-2,686.55%
-39.72%
Free Cash Flow
- -
95.54%
-22.36%
Net Income, GAAP
- -
185.67%
16.31%
Sales/Revenue/Turnover
- -
- -
48.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
1
2023
- -
- -
- -
- -
1
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.02
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Modern Mobility Aids, Inc. (MDRM)
Medical System Network Co., Ltd. (4350.T)
Swedish Orphan Biovitrum AB (SOBI.ST)
Wuhan General Group (China), Inc. (WUHN)
Trulieve Cannabis Corp. (TRLV)
HealthWarehouse.com, Inc. (HEWA)
Business
Kanabo Group Plc is a digital health enterprise focused on delivering specialized medicines and services, concentrating on the development and provision of cannabis-derived treatments for medical patients, alongside non-tetrahydrocannabinol products for general wellness consumers. The company markets its offerings under the distinctive Kanabo brand, which encompass innovative inhalation technologies and a dedicated telehealth platform. Founded in 2016, the firm maintains its primary operations in London, United Kingdom, with its research and development activities based in Israel. Recently, trading in its shares on the London Stock Exchange has been temporarily suspended, as the company undertakes a comprehensive review of its strategic direction.